Key result
Bay leaf extract and atorvastatin reduce hepatic lipids and liver-kidney injury markers in rats.
RCT (n=40)
Randomly classified into 4 groups
Answers are grounded in this paper and cite their sources.
Introduction: Hyperlipidemia associated with increase of atherosclerosis and heart, blood vessels diseases.the present study was discuss of potentials effect of bay leave extract (BLE) and atorvastatin drug at dietwith high fat, feeding rat types. Material and Methods: The Rats were randomly classificationfor 4 groupseach group have 10 rats. control feed standard diet, group two rats feed HFD, group three rats feed HFD +( BLE 250mg/kg ) and group four rats feed HFD + Atorvastatin 20 mg/kg in the experiment, the treatmentdone by gavage and treated with 4 weeks daily. Results and Conclusion: The results show increasedsignificantly at the end body weights also the weight gain at group two by treated (HFD) , while hepaticlevels was inhibited for the cholesterol, and also triglycerides, also the low-density lipoprotein cholesterol;While the hepatic levels and serum of high-density lipoprotein cholesterol may be increased when theanimal treated 250 mg/kg BLE and 20mg/kg atorvastatin , also the result showed increased significantlyin serum AST ,ALT, ALP, urea and creatinine in group of animals treated HFD , and caused decreasedsignificantly in the value of above parameters when the animals treated 250 mg/kg BLE and 20mg/kgatorvastatin ,it reach the control. In conclusion, bay leave exerts and atorvastatin have amelioration effectagainst hyperlipidemia in HFD-fed rats.
No takes yet. Share an insight, caveat, or question.
Faraj Hato (2022) conducted an RCT in Hyperlipidemia (High-fat diet-induced in male rats) (n=40). Laurus nobilis (bay leaf) extract (BLE) and Atorvastatin vs. High-fat diet (HFD) alone and standard control diet was evaluated on Hepatic lipid profile (cholesterol, triglycerides, LDL-C, HDL-C) and serum liver and kidney function parameters (AST, ALT, ALP, urea, creatinine). Bay leaf extract and atorvastatin for 4 weeks reduced hepatic lipids and serum AST, ALT, ALP, urea, and creatinine in HFD-fed rats.
Synapse has enriched 10 related papers. Consider them for comparative context: